RecruitingNCT00439049

Substance Abuse Pre-Treatment Screening Study

General Evaluation of Eligibility for Substance Abuse/Dependence Research

Sponsor

The University of Texas Health Science Center, Houston

Enrollment

7,500 participants

Start Date

Oct 1, 2005

Study Type

OBSERVATIONAL

Conditions

Substance Abuse Alcohol Dependence Cocaine Dependence Opiate Dependence Cocaine Abuse

Summary

The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called L-Dopa, a drug called Naltrexone, and others for people with alcohol dependence, cocaine abuse, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.